| Year |
Citation |
Score |
| 2024 |
O'Connell CJ, Brown RS, Peach TM, Traubert OD, Schwierling HC, Notorgiacomo GA, Robson MJ. Strain in the Midbrain: Impact of Traumatic Brain Injury on the Central Serotonin System. Brain Sciences. 14. PMID 38248266 DOI: 10.3390/brainsci14010051 |
0.329 |
|
| 2024 |
O'Connell CJ, Reeder EL, Hymore JA, Brown RS, Notorgiacomo GA, Collins SM, Gudelsky GA, Robson MJ. Transcriptomic dynamics governing serotonergic dysregulation in the dorsal raphe nucleus following mild traumatic brain injury. Experimental Neurology. 374: 114695. PMID 38246304 DOI: 10.1016/j.expneurol.2024.114695 |
0.334 |
|
| 2023 |
Luis TC, Barkas N, Carrelha J, Giustacchini A, Mazzi S, Norfo R, Wu B, Aliouat A, Guerrero JA, Rodriguez-Meira A, Bouriez-Jones T, Macaulay IC, Jasztal M, Zhu G, Ni H, ... Robson MJ, et al. Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner. Nature Communications. 14: 6062. PMID 37770432 DOI: 10.1038/s41467-023-41691-y |
0.451 |
|
| 2023 |
Ren J, Liu K, Wu B, Lu X, Sun L, Privratsky JR, Xing C, Robson MJ, Mao H, Blakely RD, Abe K, Souma T, Crowley SD. Divergent Actions of Renal Tubular and Endothelial Type 1 Interleukin-1 Receptor Signaling in Toxin-induced Acute Kidney Injury. Journal of the American Society of Nephrology : Jasn. PMID 37545036 DOI: 10.1681/ASN.0000000000000191 |
0.51 |
|
| 2022 |
Reeder EL, O'Connell CJ, Collins SM, Traubert OD, Norman SV, Cáceres RA, Sah R, Smith DW, Robson MJ. Increased Carbon Dioxide Respiration Prevents the Effects of Acceleration/Deceleration Elicited Mild Traumatic Brain Injury. Neuroscience. PMID 36332692 DOI: 10.1016/j.neuroscience.2022.10.016 |
0.525 |
|
| 2022 |
Singer KE, McGlone ED, Collins SM, Wallen TE, Morris MC, Schuster RM, England LG, Robson MJ, Goodman MD. Propranolol Reduces p-tau Accumulation and Improves Behavior Outcomes in a Polytrauma Murine Model. The Journal of Surgical Research. 282: 183-190. PMID 36308901 DOI: 10.1016/j.jss.2022.09.017 |
0.492 |
|
| 2022 |
O'Connell CJ, Reeder EL, Collins SM, Lungani K, Norman SV, Robson MJ. Mild traumatic brain injury elicits time- and region-specific reductions in serotonin transporter protein expression and uptake capacity. Neuroreport. 33: 612-616. PMID 36062511 DOI: 10.1097/WNR.0000000000001822 |
0.582 |
|
| 2022 |
Collins SM, O'Connell CJ, Reeder EL, Norman SV, Lungani K, Gopalan P, Gudelsky GA, Robson MJ. Altered Serotonin 2A (5-HT) Receptor Signaling Underlies Mild TBI-Elicited Deficits in Social Dominance. Frontiers in Pharmacology. 13: 930346. PMID 35910378 DOI: 10.3389/fphar.2022.930346 |
0.6 |
|
| 2021 |
Ren J, Lu X, Hall G, Privratsky JR, Robson MJ, Blakely RD, Crowley SD. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage. American Journal of Physiology. Renal Physiology. PMID 34894725 DOI: 10.1152/ajprenal.00353.2021 |
0.519 |
|
| 2020 |
Logsdon AF, Lucke-Wold BP, Turner RC, Collins SM, Reeder EL, Huber JD, Rosen CL, Robson MJ, Plattner F. Low-intensity Blast Wave Model for Preclinical Assessment of Closed-head Mild Traumatic Brain Injury in Rodents. Journal of Visualized Experiments : Jove. PMID 33226021 DOI: 10.3791/61244 |
0.516 |
|
| 2020 |
Quinlan MA, Robson MJ, Ye R, Rose KL, Schey KL, Blakely RD. Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant. Frontiers in Molecular Neuroscience. 13: 89. PMID 32581705 DOI: 10.3389/Fnmol.2020.00089 |
0.576 |
|
| 2020 |
Benton AA, Collins SM, Robson MJ. Transient Reductions in Serotonin Transporter Expression and Function Elicited by Blast‐Induced Traumatic Brain Injury The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.06052 |
0.573 |
|
| 2020 |
Reeder EL, Collins SM, Gopalan P, Norman SV, O'Connell CJ, Robson MJ. IRAK4 Inhibition Attenuates Interleukin‐1‐Induced Astrogliosis: A Potential Therapeutic Target for Neurodegenerative Disorders? The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.05220 |
0.506 |
|
| 2020 |
Collins SM, Reeder EL, O’Connell CJ, Gudelsky GA, Robson MJ. Blast‐induced Traumatic Brain Injury Elicits Sociability Deficits and Aggressive Behaviors Coinciding with Transient Variations in CNS 5‐HT Levels and 5‐HT
2A
Hypersensitivity The Faseb Journal. 34: 1-1. DOI: 10.1096/Fasebj.2020.34.S1.04313 |
0.546 |
|
| 2019 |
Thome JG, Reeder EL, Collins SM, Gopalan P, Robson MJ. Contributions of Interleukin-1 Receptor Signaling in Traumatic Brain Injury. Frontiers in Behavioral Neuroscience. 13: 287. PMID 32038189 DOI: 10.3389/Fnbeh.2019.00287 |
0.605 |
|
| 2019 |
Liu X, Nemeth DP, McKim DB, Zhu L, DiSabato DJ, Berdysz O, Gorantla G, Oliver B, Witcher KG, Wang Y, Negray CE, Vegesna RS, Sheridan JF, Godbout JP, Robson MJ, et al. Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities. Immunity. 50: 764-766. PMID 30893590 DOI: 10.1016/J.Immuni.2019.02.012 |
0.541 |
|
| 2019 |
Liu X, Nemeth DP, McKim DB, Zhu L, DiSabato DJ, Berdysz O, Gorantla G, Oliver B, Witcher KG, Wang Y, Negray CE, Vegesna RS, Sheridan JF, Godbout JP, Robson MJ, et al. Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities. Immunity. PMID 30683620 DOI: 10.1016/J.Immuni.2018.12.012 |
0.557 |
|
| 2019 |
Quinlan MA, Krout D, Katamish R, Robson MJ, Nettesheim C, Gresch PJ, Mash D, Henry K, Blakely RD. Human Serotonin Transporter Coding Variation Establishes Conformational Bias with Functional Consequences. Acs Chemical Neuroscience. PMID 30668912 DOI: 10.1021/Acschemneuro.8B00689 |
0.553 |
|
| 2019 |
Logsdon AF, Lucke-Wold BP, Thome JG, Turner RC, Robson MJ. Abstract # 3078 Contributions of astrocytic IL-1R1 signaling in blast-induced traumatic brain injury Brain Behavior and Immunity. 76. DOI: 10.1016/J.Bbi.2018.11.207 |
0.416 |
|
| 2019 |
Liu X, Nemeth D, McKim D, Zhu L, DiSabato D, Berdysz O, Gorantla G, Oliver B, Witcher K, Wang Y, Sheridan J, Godbout J, Robson M, Blakely R, Popovich P, et al. Abstract # 2075 Structural and functional cytoarchitecture of IL-1R1-expressing system in the brain Brain Behavior and Immunity. 76. DOI: 10.1016/J.Bbi.2018.11.201 |
0.538 |
|
| 2019 |
Baganz N, Smith J, Harbom L, Castriz E, Robson M, Blakely R. Abstract # 2043 Contributions of inflammatory cytokine signaling to the enduring effects of early-life stress: A serotonin connection? Brain, Behavior, and Immunity. 76: e2. DOI: 10.1016/J.Bbi.2018.11.176 |
0.59 |
|
| 2018 |
Robson MJ, Quinlan MA, Margolis KG, Gajewski-Kurdziel PA, Veenstra-VanderWeele J, Gershon MD, Watterson DM, Blakely RD. p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouse. Proceedings of the National Academy of Sciences of the United States of America. PMID 30297392 DOI: 10.1073/Pnas.1809137115 |
0.677 |
|
| 2018 |
Burke SJ, Batdorf HM, Burk DH, Martin TM, Mendoza T, Stadler K, Alami W, Karlstad MD, Robson MJ, Blakely RD, Mynatt RL, Collier JJ. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation. Molecular Metabolism. PMID 29914854 DOI: 10.1016/J.Molmet.2018.06.003 |
0.526 |
|
| 2017 |
Robson MJ, Quinlan MA, Blakely RD. Immune System Activation and Depression: Roles of Serotonin in the Central Nervous System and Periphery. Acs Chemical Neuroscience. PMID 28345868 DOI: 10.1021/Acschemneuro.6B00412 |
0.545 |
|
| 2017 |
Robson M, Quinlan M, Veenstra-VanderWeele J, Watterson D, Blakely R. Do neuroinflammatory pathways contribute to serotoninergic alterations in autism? p38alpha MAPK signaling drives perturbed serotonin clearance, receptor hypersensitivity, and social behavior deficits in the SERT Ala56 mouse Brain, Behavior, and Immunity. 66: e36. DOI: 10.1016/J.Bbi.2017.07.131 |
0.687 |
|
| 2016 |
Robson MJ, Zhu CB, Quinlan MA, Botschner DA, Baganz NL, Lindler KM, Thome JG, Hewlett WA, Blakely RD. Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1. Plos One. 11: e0150068. PMID 26930558 DOI: 10.1371/Journal.Pone.0150068 |
0.556 |
|
| 2015 |
Turner RC, Lucke-Wold BP, Logsdon AF, Robson MJ, Dashnaw ML, Huang JH, Smith KE, Huber JD, Rosen CL, Petraglia AL. The Quest to Model Chronic Traumatic Encephalopathy: A Multiple Model and Injury Paradigm Experience. Frontiers in Neurology. 6: 222. PMID 26539159 DOI: 10.3389/Fneur.2015.00222 |
0.304 |
|
| 2015 |
Baganz NL, Lindler KM, Zhu CB, Smith JT, Robson MJ, Iwamoto H, Deneris ES, Hewlett WA, Blakely RD. A requirement of serotonergic p38α mitogen-activated protein kinase for peripheral immune system activation of CNS serotonin uptake and serotonin-linked behaviors. Translational Psychiatry. 5: e671. PMID 26529424 DOI: 10.1038/Tp.2015.168 |
0.589 |
|
| 2015 |
Lucke-Wold BP, Naser ZJ, Logsdon AF, Turner RC, Smith KE, Robson MJ, Bailes JE, Lee JM, Rosen CL, Huber JD. Amelioration of nicotinamide adenine dinucleotide phosphate-mediated stress reduces cell death after blast-induced traumatic brain injury. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 26414010 DOI: 10.1016/J.Trsl.2015.08.005 |
0.326 |
|
| 2015 |
Nguyen L, Lucke-Wold BP, Mookerjee SA, Cavendish JZ, Robson MJ, Scandinaro AL, Matsumoto RR. Role of sigma-1 receptors in neurodegenerative diseases. Journal of Pharmacological Sciences. 127: 17-29. PMID 25704014 DOI: 10.1016/J.Jphs.2014.12.005 |
0.349 |
|
| 2014 |
Logsdon AF, Turner RC, Lucke-Wold BP, Robson MJ, Naser ZJ, Smith KE, Matsumoto RR, Huber JD, Rosen CL. Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms. Frontiers in Cellular Neuroscience. 8: 421. PMID 25540611 DOI: 10.3389/Fncel.2014.00421 |
0.341 |
|
| 2014 |
Nguyen L, Kaushal N, Robson MJ, Matsumoto RR. Sigma receptors as potential therapeutic targets for neuroprotection. European Journal of Pharmacology. 743: 42-7. PMID 25261035 DOI: 10.1016/J.Ejphar.2014.09.022 |
0.35 |
|
| 2014 |
Nguyen L, Robson MJ, Healy JR, Scandinaro AL, Matsumoto RR. Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan. Plos One. 9: e89985. PMID 24587167 DOI: 10.1371/Journal.Pone.0089985 |
0.334 |
|
| 2014 |
Robson MJ, Turner RC, Naser ZJ, McCurdy CR, O'Callaghan JP, Huber JD, Matsumoto RR. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation. Experimental Neurology. 254: 180-9. PMID 24508558 DOI: 10.1016/J.Expneurol.2014.01.020 |
0.395 |
|
| 2014 |
Matsumoto RR, Nguyen L, Kaushal N, Robson MJ. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects. Advances in Pharmacology (San Diego, Calif.). 69: 323-86. PMID 24484982 DOI: 10.1016/B978-0-12-420118-7.00009-3 |
0.329 |
|
| 2014 |
Kaushal N, Robson MJ, Rosen A, McCurdy CR, Matsumoto RR. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro. European Journal of Pharmacology. 724: 193-203. PMID 24380829 DOI: 10.1016/J.Ejphar.2013.12.039 |
0.313 |
|
| 2013 |
Turner RC, Naser ZJ, Logsdon AF, DiPasquale KH, Jackson GJ, Robson MJ, Gettens RT, Matsumoto RR, Huber JD, Rosen CL. Modeling clinically relevant blast parameters based on scaling principles produces functional & histological deficits in rats. Experimental Neurology. 248: 520-9. PMID 23876514 DOI: 10.1016/J.Expneurol.2013.07.008 |
0.323 |
|
| 2013 |
Robson MJ, Seminerio MJ, McCurdy CR, Coop A, Matsumoto RR. σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation. Pharmacological Reports : Pr. 65: 343-9. PMID 23744418 DOI: 10.1016/S1734-1140(13)71009-0 |
0.345 |
|
| 2013 |
Robson MJ, Turner RC, Naser ZJ, McCurdy CR, Huber JD, Matsumoto RR. SN79, a sigma receptor ligand, blocks methamphetamine-induced microglial activation and cytokine upregulation. Experimental Neurology. 247: 134-42. PMID 23631864 DOI: 10.1016/J.Expneurol.2013.04.009 |
0.411 |
|
| 2013 |
Kaushal N, Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 960-71. PMID 22921523 DOI: 10.1016/J.Euroneuro.2012.08.005 |
0.371 |
|
| 2012 |
Turner RC, Lucke-Wold BP, Robson MJ, Omalu BI, Petraglia AL, Bailes JE. Repetitive traumatic brain injury and development of chronic traumatic encephalopathy: a potential role for biomarkers in diagnosis, prognosis, and treatment? Frontiers in Neurology. 3: 186. PMID 23335911 DOI: 10.3389/Fneur.2012.00186 |
0.319 |
|
| 2012 |
Seminerio MJ, Robson MJ, McCurdy CR, Matsumoto RR. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus. European Journal of Pharmacology. 691: 103-9. PMID 22820108 DOI: 10.1016/J.Ejphar.2012.07.029 |
0.389 |
|
| 2012 |
Xu YT, Robson MJ, Szeszel-Fedorowicz W, Patel D, Rooney R, McCurdy CR, Matsumoto RR. CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain. Pharmacology, Biochemistry, and Behavior. 101: 174-80. PMID 22234290 DOI: 10.1016/J.Pbb.2011.12.016 |
0.302 |
|
| 2012 |
Seminerio MJ, Robson MJ, Abdelazeem AH, Mesangeau C, Jamalapuram S, Avery BA, McCurdy CR, Matsumoto RR. Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine. The Aaps Journal. 14: 43-51. PMID 22183188 DOI: 10.1208/S12248-011-9311-8 |
0.339 |
|
| 2012 |
Robson MJ, Elliott M, Seminerio MJ, Matsumoto RR. Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 308-17. PMID 21911285 DOI: 10.1016/J.Euroneuro.2011.08.002 |
0.339 |
|
| 2010 |
Fishback JA, Robson MJ, Xu YT, Matsumoto RR. Sigma receptors: potential targets for a new class of antidepressant drug. Pharmacology & Therapeutics. 127: 271-82. PMID 20438757 DOI: 10.1016/J.Pharmthera.2010.04.003 |
0.308 |
|
| Show low-probability matches. |